Chase Leavitt was Appointed as General Counsel and Corporate Secretary at BioTime

Date of management change: May 22, 2019 

What Happened?

Alameda, -based BioTime Appointed Chase Leavitt as General Counsel and Corporate Secretary


About the Company

BioTime is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. BioTime`s pipeline is based on two platform technologies which encompass cell replacement and cell/drug delivery. BioTime`s lead cell replacement product candidate is OpRegen®, a retinal pigment epithelium transplant therapy in Phase 2 development for the treatment of dry age-related macular degeneration, the leading cause of blindness in the developed world. BioTime common stock is traded on the NYSE American and TASE under the symbol BTX.


About the Person

Chase Leavitt is General Counsel and Corporate Secretary at BioTime. Previously, Chase held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Ng Bryan, Kesselman Marc, Colson Christopher, Davis Kevin, Wein Ettenberg Felecia, Malin Zoellner Alison, Reach Abbey, Hoyles Jonathan, Staley Melinda, Doyle Brian, Ebrahemi Fred

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.